Latest Insights & Research

Stay informed with the latest public health research, insights, and evidence-based analysis from our team of experts.

Epi

The Rising Threat of the H3N2 Flu Virus

Public health experts are ringing alarm bells as a new wave of the H3N2 influenza virus emerges, posing a significant threat globally. With the winter season approaching, healthcare systems, particularly in the EU and the US, are preparing for what could be one of the most severe flu seasons in recent years. The H3N2 Virus: […]

Read more →
Epi

Rising Health Concerns: Mpox, Botox, and Mental Health Diagnostics

Emerging infectious diseases, cosmetic interventions, and mental health diagnostics characterize this week’s public health landscape. New Mpox Strain in England A novel mpox strain has made its presence felt in England. This variant, a mix of two major virus types, was recently identified in an individual who returned from Asia. The emergence of such a […]

Read more →
Epi

A Conversation with Brandi Williams

Public health emergencies rarely unfold as protocols imagine, especially in rural and agricultural communities. Few people understand that better than Brandi Williams, an epidemiologist who has spent the past several years responding to crises ranging from avian influenza to opioid overdoses to COVID-19. In this conversation, Brandi walks through the complex, often overlooked challenges that […]

Read more →
Epi

Respiratory Illnesses Surge in November 2025

The global health community is grappling with an unexpected and significant uptick in respiratory illnesses in November 2025. Recent reports from various public health departments highlight a troubling trend: respiratory illnesses, including flu and other viral infections, are on the rise, posing challenges for healthcare providers and policy makers worldwide. Current Trends and Data Analysis […]

Read more →
Epi

Haiti’s Battle Against Rabies

In the heart of the Caribbean, Haiti is waging a fierce battle against the deadly threat of rabies, turning a public health challenge into an opportunity for systemic improvement, thanks to vaccines and international support. The UN and its health arm, the Pan American Health Organization (PAHO), are at the forefront of this vital effort. […]

Read more →
Epi

Early Flu Season Warning: Rising Pandemic in Pediatric Cases

The flu season has made an early appearance this year, and health officials are raising alarms about the increasing number of cases among children. With a noticeable surge in cases across various regions, the call to action involves vaccination and heightened preventive measures. Why Is This Flu Season Starting Earlier? Typically, flu season ramps up […]

Read more →
Epi

A Surge in Antibiotic Resistance

Understanding the Rising Threat of Antibiotic Resistance The landscape of public health is facing a seismic shift due to the escalating threat of antibiotic resistance. Recent data, encapsulated by a report from the World Health Organization (WHO), highlights a grim reality: one in six bacterial infections globally are now resistant to standard antibiotics. This growing […]

Read more →
Developmental disorders

How New Data Could Improve Autism Programs in MENA

The recent autism-Tylenol claims coming out of the US may narrow our vision to a US-centric approach. Last year, a pediatrician in Cairo described how families often arrive at her clinic years after their child’s first symptoms of autism spectrum disorder (ASD). “Parents usually suspect something is different,” she said, “but stigma and lack of […]

Read more →
Communication

Trump’s Tylenol and Autism Claims

President Trump’s remarks linking Tylenol (acetaminophen) to autism has reignited public health debates globally. Experts have voiced concerns over the implications this misinformation may have on public perception and health practices. This article aims to examine these claims, assess the scientific evidence, and explore the broader public health implications. Understanding the Claims On Monday, President […]

Read more →

Get the public-health insights you need—
every Thursday morning.

We scan 70+ journals so you don't have to.
One email. Zero jargon. Unsubscribe anytime.

🔒 No spam. 1-click opt-out. Privacy-first.